A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Trials Related to Jazz Pharmaceuticals
Related studies linked through entity extraction aliases.
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
- Status
- COMPLETED
- Phase
- N/A
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola
- Status
- WITHDRAWN
- Phase
- PHASE2
A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- Status
- TERMINATED
- Phase
- PHASE3
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE3
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea
- Status
- COMPLETED
- Phase
- NA
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
- Status
- WITHDRAWN
- Phase
- PHASE4
A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
- Status
- COMPLETED
- Phase
- PHASE4
A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3